Cargando…
Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
Existing algorithms account for ~50% of observed variance in warfarin dose requirements after including common polymorphisms. However, they do not perform as well in populations other than Caucasians, in part because some ethno-specific genetic variants are overlooked. The objective of the present s...
Autores principales: | Claudio-Campos, Karla, Labastida, Aurora, Ramos, Alga, Gaedigk, Andrea, Renta-Torres, Jessicca, Padilla, Dariana, Rivera-Miranda, Giselle, Scott, Stuart A., Ruaño, Gualberto, Cadilla, Carmen L., Duconge-Soler, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461284/ https://www.ncbi.nlm.nih.gov/pubmed/28638342 http://dx.doi.org/10.3389/fphar.2017.00347 |
Ejemplares similares
-
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016) -
Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program
por: Hernandez-Suarez, Dagmar F., et al.
Publicado: (2018) -
Discovery of Ancestry-specific Variants Associated with Clopidogrel Response among Caribbean Hispanics
por: Yang, Guang, et al.
Publicado: (2023) -
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
por: Hernandez-Suarez, Dagmar F, et al.
Publicado: (2018) -
Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach
por: Duconge, Jorge, et al.
Publicado: (2021)